What is the price target for ACM stock?
18 analysts have analysed ACM and the average price target is 124.35 USD. This implies a price increase of 47.85% is expected in the next year compared to the current price of 84.1.
NYSE:ACM • US00766T1007
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AECOM (ACM).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-27 | Citigroup | Maintains | Buy -> Buy |
| 2026-04-20 | Truist Securities | Maintains | Buy -> Buy |
| 2026-02-11 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-11 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-11 | Truist Securities | Reiterate | Buy -> Buy |
| 2026-02-10 | UBS | Maintains | Buy -> Buy |
| 2026-02-10 | B of A Securities | Maintains | Buy -> Buy |
| 2026-01-28 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-01-26 | Citigroup | Maintains | Buy -> Buy |
| 2026-01-21 | UBS | Maintains | Buy -> Buy |
| 2025-12-22 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-12-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-21 | Truist Securities | Maintains | Buy -> Buy |
| 2025-11-21 | Baird | Downgrade | Outperform -> Neutral |
| 2025-11-20 | Argus Research | Maintains | Buy -> Buy |
| 2025-11-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-19 | UBS | Maintains | Buy -> Buy |
| 2025-11-19 | Baird | Maintains | Outperform -> Outperform |
| 2025-11-19 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-20 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-10-20 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-08 | Truist Securities | Maintains | Buy -> Buy |
| 2025-08-12 | Barclays | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.378B 9.36% | 16.105B 12.01% | 16.14B 0.21% | 8.015B -50.34% | 8.501B 6.06% | 10.719B 26.09% | N/A | N/A | |
| EBITDA YoY % growth | 966.7M 10.87% | 1.103B 14.10% | 1.235B 11.94% | 1.315B 6.50% | 1.442B 9.66% | 1.585B 9.92% | 1.809B 14.13% | 1.877B 3.76% | |
| EBIT YoY % growth | 791M 12.84% | 924.236M 16.84% | 1.059B 14.57% | 1.197B 13.05% | 1.313B 9.69% | 1.427B 8.68% | 1.703B 19.34% | 1.761B 3.41% | |
| Operating Margin | 5.50% | 5.74% | 6.56% | 14.93% | 15.45% | 13.31% | N/A | N/A | |
| EPS YoY % growth | 3.73 7.49% | 4.52 21.18% | 5.26 16.37% | 6.01 14.17% | 6.70 11.49% | 7.57 13.08% | 9.12 20.46% | 9.71 6.42% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.57 25.45% | 1.58 17.85% | 1.54 13.11% | 1.40 8.59% | 1.51 -3.82% | 1.74 10.22% | 1.86 20.81% | 1.55 10.31% | 1.68 11.16% | 1.92 10.25% | 1.99 7.07% |
| Revenue Q2Q % growth | 1.96B -48.03% | 2.103B -49.67% | 2.102B -49.66% | 1.957B -48.91% | 2.063B 5.26% | 2.158B 2.62% | 2.182B 3.81% | 3.167B 61.83% | 2.987B 44.79% | 3.264B 51.25% | 3.216B 47.39% |
| EBITDA Q2Q % growth | 312.94M -6.45% | 351.07M -15.84% | 348.2M -25.49% | 315.1M 7.84% | 329.42M 5.27% | 372.27M 6.04% | 378.42M 8.68% | 331.73M 5.28% | 355.15M 7.81% | 403.45M 8.38% | 414M 9.40% |
| EBIT Q2Q % growth | 286.03M 14.09% | 322.04M 11.51% | 322.35M 10.61% | 289.72M 20.64% | 304.68M 6.52% | 341.19M 5.95% | 346.68M 7.55% | 299.07M 3.23% | 321.15M 5.41% | 362.73M 6.31% | 374.07M 7.90% |
All data in USD
18 analysts have analysed ACM and the average price target is 124.35 USD. This implies a price increase of 47.85% is expected in the next year compared to the current price of 84.1.
AECOM (ACM) will report earnings on 2026-05-11.
The consensus EPS estimate for the next earnings of AECOM (ACM) is 1.57 USD and the consensus revenue estimate is 1.96B USD.
The consensus rating for AECOM (ACM) is 81.1111 / 100 . This indicates that analysts generally have a positive outlook on the stock.